CTX Lifesciences, a vertically integrated API and intermediate manufacturing company was established in the year of 2004 in Surat, India as a part of privately held group which is worth US$ 600 million.

With more than 1000 KL of total reactor volume capacity spread across five manufacturing blocks, CTX has access to its own infrastructure viz water reservoir, land fill site, effluent treatment plant and incinerators. Facility spread across 32 acres is USFDA inspected, EU GMP certified, WHO GMP certified and has received accreditations from several international drug authorities. Today, CTX supports the Global Pharmaceutical Industry with supply of its APIs across 70 nations.

Moreover Regulatory markets are well catered with 14 assessed USDMFs and 14 approved CEPs.